Chondrex

What Chondrex does

Chondrex, Inc. is a privately held, specialized life-science reagent supplier founded in 1996 and headquartered in Woodinville, Washington, operating with a 1–10 person team. The company focuses on the biochemistry and immunology of collagen and collagen-related materials, providing highly purified collagens (types I, II, III, IV, V, IX, XI across more than ten species), monoclonal antibodies, ELISA assay kits, adjuvants (Complete/Incomplete Freund's Adjuvant and Muramyl Dipeptide), and complete reagent sets for in-vivo disease models including Collagen-Induced Arthritis (CIA), Collagen Antibody-Induced Arthritis (CAIA), DSS-Colitis, and nephritis. Differentiating capabilities include proprietary purification methods (repetitive salt precipitation and DEAE-cellulose chromatography) that produce low-antigenicity collagen preparations offered in multiple grades (immunization, cell culture, ELISA, T-cell assay), and a growing catalog of application-specific protocols and kits in allergy (e.g., peanut Ara h 1/2, Alternaria Alt a 1), NETs, and paracellular permeability research.

Chondrex monetizes primarily through one-time direct purchases of reagents via its e-commerce storefront (chondrex.com) at unit prices ranging from approximately $18 to $3,770, with quote-based bulk pricing available. Distribution combines direct online sales with a network of international distributors enabling global reach. The customer base is horizontally segmented: the primary segment is academic and institutional life-science researchers studying arthritis, inflammation, allergy, connective tissue disease, and nephritis, with a secondary segment of pharmaceutical, biotech, and contract research organizations using the reagents for preclinical drug discovery.

The company has invested recently in product-line extension rather than scale expansion: 2026 launches include lyophilized FITC-labeled bovine Type II collagen, recombinant Alternaria allergen, peanut-allergen IgE ELISA kits, immunization-grade Type III collagen, and three new application protocols. No funding rounds, acquisitions, leadership changes, or AI/ML capabilities are disclosed, and revenue is not publicly reported. Strategic posture is that of an entrenched, specialist reagent supplier extending its catalog and protocol footprint steadily rather than scaling headcount or pursuing capital-funded expansion.

Name

Chondrex

Legal name

Chondrex, Inc.

Website

https://chondrex.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

1–10 employees

Short description

Chondrex is a privately held Woodinville, Washington-based reagent supplier specializing in purified collagens, monoclonal antibodies, ELISA kits, and adjuvants for arthritis, inflammation, allergy, and nephritis research, serving academic labs, pharmaceutical R&D, and CROs globally through direct e-commerce and distributors.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• Collagen reagents
• Research antibodies
• ELISA assay kits
• Inflammation research
• Arthritis disease models

Headquarters

HQ city

Woodinville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Research Reagent Sales: Chondrex generates revenue through the sale of high-quality research reagents including collagen products, monoclonal antibodies, assay kits, adjuvants, and related biochemicals. Products are sold directly via their e-commerce platform with pricing ranging from approximately $18 to $3,770 per unit depending on the product type and quantity. Bulk quantities are available at discounted prices.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Chondrex manufactures and sells highly purified collagen reagents (Types I, II, III, IV, V, IX, XI from multiple species), monoclonal antibodies, ELISA assay kits, adjuvants, and complete reagent sets for arthritis, inflammation, allergy, connective tissue, and nephritis research. Its products support academic researchers, pharmaceutical/biotech firms, and contract research organizations performing animal disease models (CIA, CAIA, DSS-colitis, nephritis) and biomarker detection assays.

Product overview

Chondrex is a specialized reagent company offering high-quality products for arthritis and inflammation research. The company provides a comprehensive portfolio of collagen products (including types I, II, III, IV, V, IX, and XI from multiple species), monoclonal antibodies, ELISA assay kits, adjuvants (Complete/Incomplete Freund's Adjuvant, MDP), and complete reagent sets for animal disease models including Collagen-Induced Arthritis (CIA), CAIA, DSS-Colitis, and nephritis models. The product line also includes NETs (Neutrophil Extracellular Traps) research kits, fungal allergen products, and immunoassay buffers. Products are available in multiple grades (immunization, cell culture, ELISA, T-cell assay) to accommodate various research needs.

Differentiator

Problem solved

Functional benefit

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• International DistributorscoreChannel Partner/ Reseller/ DistributorChondrex maintains a network of international distributors to serve researchers globally outside the United States. These distributors enable local sales, shipping, and customer support for the company's research reagent products in international markets.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Abcam: Abcam is a global antibody and reagent supplier with broad coverage of research applications including collagen and inflammation-related targets, competing with Chondrex for life science research dollars.
• Bio-Techne (R&D Systems): Bio-Techne owns R&D Systems and Novus Biologicals, offering an extensive catalog of antibodies, ELISA kits, and proteins including collagen-related reagents that overlap with Chondrex's portfolio.
• MilliporeSigma (Sigma-Aldrich): MilliporeSigma supplies collagen types, biochemicals, and immunological reagents used in arthritis and inflammation research, representing a major incumbent competing with Chondrex on catalog breadth.
• Cell Signaling Technology: Cell Signaling Technology produces high-quality antibodies and ELISA kits used in inflammation and immunology research, representing a larger incumbent with overlapping antibody and assay offerings.
• Thermo Fisher Scientific: Thermo Fisher Scientific (including Invitrogen, Gibco, and Thermo Scientific brands) is the largest life science tools company, offering collagen, antibodies, ELISA kits, and adjuvants that compete broadly with Chondrex's catalog.

Direct peers

• Cayman Chemical: Cayman Chemical is a biochemical reagent supplier offering ELISA kits, antibodies, and assay reagents for inflammation and immunology research, competing with Chondrex in similar academic and CRO customer segments.
• MD Bioproducts: MD Bioproducts specializes in collagen-induced arthritis (CIA) and collagen antibody-induced arthritis (CAIA) reagents, monoclonal antibodies, and ELISA kits for inflammatory disease research, directly overlapping Chondrex's flagship product lines.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology offers a broad portfolio of antibodies and research reagents including collagen-related products, competing directly with Chondrex for academic and preclinical research customers.
• Enzo Life Sciences: Enzo Life Sciences provides biochemical and immunological assay kits, antibodies, and reagents for inflammation and autoimmune disease research, with overlap to Chondrex's ELISA and assay kit offerings.
• Hooke Laboratories: Hooke Laboratories provides CIA and CAIA model kits, collagen antibodies, and arthritis research reagents that compete head-to-head with Chondrex in academic and pharma preclinical research markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/chondrexinc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chondrex